Business Standard

Monday, December 23, 2024 | 09:59 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Syncom Formulations (India) standalone net profit rises 3.49% in the December 2022 quarter

Image

Capital Market

Sales rise 0.26% to Rs 57.38 crore

Net profit of Syncom Formulations (India) rose 3.49% to Rs 4.15 crore in the quarter ended December 2022 as against Rs 4.01 crore during the previous quarter ended December 2021. Sales rose 0.26% to Rs 57.38 crore in the quarter ended December 2022 as against Rs 57.23 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales57.3857.23 0 OPM %10.308.53 -PBDT7.176.97 3 PBT5.975.98 0 NP4.154.01 3

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 14 2023 | 7:48 AM IST

Explore News